Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MEDICAL EQUIPMENT RENTAL MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL MEDICAL EQUIPMENT RENTAL MARKETSIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL MEDICAL EQUIPMENT RENTAL MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.10 ECONOMIC DEVELOPMENT
16. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, BY PRODUCT
16.1 OVERVIEW
(NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)
16.2 PERSONAL/HOME CARE PRODUCTS
16.2.1 MOBILITY AIDS & ASSISTIVE DEVICES
16.2.1.1. WHEELCHAIRS
16.2.1.1.1. MANUAL WHEELCHAIRS
16.2.1.1.2. ELECTRIC (POWERED) WHEELCHAIRS
16.2.1.1.2.1 STANDARD ELECTRIC WHEELCHAIRS
16.2.1.1.2.2 HEAVY-DUTY/BARIATRIC ELECTRIC WHEELCHAIRS
16.2.1.1.2.3 STANDING POWER WHEELCHAIRS
16.2.1.1.2.4 FOLDING & PORTABLE POWER WHEELCHAIRS
16.2.1.1.2.5 OTHERS
16.2.1.2. WALKERS & ROLLATORS
16.2.1.2.1. WALKERS
16.2.1.2.1.1 STANDARD WALKERS (NO WHEELS)
16.2.1.2.1.2 TWO-WHEEL WALKERS
16.2.1.2.2. ROLLATORS
16.2.1.2.2.1 THREE-WHEEL ROLLATORS
16.2.1.2.2.2 FOUR-WHEEL ROLLATORS WITH SEATS
16.2.1.2.2.3 UPRIGHT WALKERS
16.2.1.3. CRUTCHES & CANES
16.2.1.3.1. CRUTCHES
16.2.1.3.1.1 UNDERARM (AXILLARY) CRUTCHES
16.2.1.3.1.2 FOREARM (LOFSTRAND) CRUTCHES
16.2.1.3.1.3 PLATFORM CRUTCHES
16.2.1.3.2. CANES
16.2.1.3.2.1 QUAD CANES
16.2.1.3.2.2 ADJUSTABLE & FOLDING CANES
16.2.1.4. MOBILITY SCOOTERS
16.2.1.4.1. 3-WHEEL MOBILITY SCOOTERS
16.2.1.4.2. 4-WHEEL MOBILITY SCOOTERS
16.2.1.4.3. OTEHRS
16.2.2 PATIENT HANDLING & TRANSFER EQUIPMENT
16.2.2.1. HOSPITAL BEDS
16.2.2.1.1. MANUAL HOSPITAL BEDS
16.2.2.1.2. SEMI-ELECTRIC HOSPITAL BEDS
16.2.2.1.3. FULLY ELECTRIC HOSPITAL BEDS
16.2.2.1.4. ICU BEDS
16.2.2.1.5. OTEHRS
16.2.2.2. PATIENT LIFTS
16.2.2.2.1. CEILING LIFTS
16.2.2.2.2. MOBILE FLOOR LIFTS
16.2.2.2.3. SIT-TO-STAND LIFTS
16.2.2.2.4. OTHERS
16.2.2.3. TRANSFER AIDS
16.2.2.3.1. STAIR LIFTS
16.2.2.3.2. WHEELCHAIR RAMPS
16.2.2.3.3. TRANSFER BOARDS
16.2.3 RESPIRATORY THERAPY EQUIPMENT
16.2.3.1. OXYGEN THERAPY EQUIPMENT
16.2.3.1.1. OXYGEN CONCENTRATORS
16.2.3.1.1.1 STATIONARY OXYGEN CONCENTRATORS
16.2.3.1.1.2 PORTABLE OXYGEN CONCENTRATORS (POC)
16.2.3.1.1.3 HIGH-FLOW OXYGEN CONCENTRATORS
16.2.3.1.2. OXYGEN CYLINDERS & TANKS
16.2.3.1.2.1 REFILLABLE OXYGEN CYLINDERS
16.2.3.1.2.2 LIQUID OXYGEN TANKS
16.2.3.1.2.3 PORTABLE OXYGEN SYSTEMS
16.2.3.2. VENTILATION EQUIPMENT
16.2.3.2.1. CPAP (CONTINUOUS POSITIVE AIRWAY PRESSURE) MACHINES
16.2.3.2.2. BIPAP (BILEVEL POSITIVE AIRWAY PRESSURE) MACHINES
16.2.3.2.3. HOME MECHANICAL VENTILATORS
16.2.3.2.4. TRANSPORT VENTILATORS
16.2.3.2.5. ICU-GRADE VENTILATORS
16.2.3.3. NEBULIZERS & AIRWAY CLEARANCE DEVICES
16.2.3.3.1. JET NEBULIZERS
16.2.3.3.2. ULTRASONIC NEBULIZERS
16.2.3.3.3. MESH NEBULIZERS
16.2.3.4. AIRWAY CLEARANCE DEVICES
16.2.3.4.1. COUGH ASSIST MACHINES
16.2.3.4.2. CHEST PERCUSSION VESTS
16.2.3.5. REHABILITATION & PHYSIOTHERAPY EQUIPMENT
16.2.3.5.1. PHYSICAL THERAPY EQUIPMENT
16.2.3.5.1.1 RESISTANCE BANDS & THERAPY BALLS
16.2.3.5.1.2 TENS (TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION) MACHINES
16.2.3.5.1.3 HYDROTHERAPY EQUIPMENT
16.3 ELECTRONIC MEDICAL EQUIPMENT
16.3.1 DIAGNOSTIC & MONITORING DEVICES
16.3.1.1. IMAGING EQUIPMENT
16.3.1.1.1. PORTABLE X-RAY MACHINES
16.3.1.1.2. ULTRASOUND MACHINES
16.3.1.1.3. MRI MACHINES
16.3.1.1.4. CT SCANNERS
16.3.1.2. VITAL SIGNS MONITORING DEVICES
16.3.1.3. BLOOD PRESSURE MONITORS
16.3.1.3.1. ECG MACHINES
16.3.1.3.2. EEG MACHINES
16.3.1.3.3. PULSE OXIMETERS
16.3.1.4. WEARABLE HEALTH DEVICES
16.3.1.5. SMARTWATCHES WITH HEALTH TRACKING
16.3.1.6. WEARABLE ECG MONITORS
16.3.2 SURGICAL & THERAPEUTIC EQUIPMENT
16.3.2.1. SURGICAL INSTRUMENTS
16.3.2.1.1. ELECTROSURGICAL UNITS (ESUS)
16.3.2.1.2. LAPAROSCOPIC INSTRUMENTS
16.3.2.1.3. ANESTHESIA MACHINES
16.3.2.2. INFUSION & DRUG DELIVERY DEVICES
16.3.2.2.1. INFUSION PUMPS
16.3.2.2.1.1 VOLUMETRIC INFUSION PUMPS
16.3.2.2.1.2 SYRINGE INFUSION PUMPS
16.3.2.2.1.3 PCA (PATIENT-CONTROLLED ANALGESIA) PUMPS
16.3.2.2.2. INSULIN PUMPS
16.3.3 HOME HEALTHCARE & TELEMEDICINE EQUIPMENT
16.3.3.1. HOME DIALYSIS EQUIPMENT
16.3.3.1.1. HEMODIALYSIS MACHINES
16.3.3.1.2. PERITONEAL DIALYSIS MACHINES
16.3.3.2. REMOTE PATIENT MONITORING (RPM) DEVICES
16.3.3.2.1. CONNECTED ECG
16.3.3.2.2. SMART GLUCOSE MONITORS
16.4 STORAGE & TRANSPORT EQUIPMENT
16.4.1 MEDICAL STORAGE SOLUTIONS
16.4.1.1. MEDICAL REFRIGERATION UNITS
16.4.1.1.1. MEDICAL FREEZERS
16.4.1.1.2. VACCINE REFRIGERATORS
16.4.1.1.3. BLOOD STORAGE REFRIGERATORS
16.4.1.2. STERILE STORAGE SOLUTIONS
16.4.1.2.1. AUTOCLAVE CABINETS
16.4.1.2.2. MEDICAL CARTS
16.4.1.2.3. SHELVING SYSTEMS
16.4.2 PATIENT TRANSPORT EQUIPMENT
16.4.2.1. AMBULANCE STRETCHERS
16.4.2.1.1. MANUAL STRETCHERS
16.4.2.1.2. HYDRAULIC STRETCHERS
16.4.2.1.3. ELECTRIC STRETCHERS
16.4.2.1.4. PEDIATRIC STRETCHERS
16.4.2.2. WHEELCHAIR VANS & MOBILITY VEHICLES
16.4.2.2.1. MODIFIED VANS
16.4.2.2.2. AMBULANCES WITH LIFTS
16.5 OTHER
17. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, BY PAYMENT MODEL
17.1 OVERVIEW
17.2 OUT-OF-POCKET PAYMENTS
17.3 INSURANCE-COVERED RENTALS
17.4 GOVERNMENT-FUNDED PROGRAMS
17.5 CORPORATE & INSTITUTIONAL LEASING
18. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, BY BUSINESS MODEL
18.1 OVERVIEW
18.2 SHORT-TERM RENTAL
18.3 LONG-TERM RENTAL
18.4 LEASE-TO-OWN
18.5 SUBSCRIPTION-BASED MODEL
18.6 PAY-PER-USE MODEL
18.7 OTHERS
19. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, BY END USER
19.1 OVERVIEW
19.2 : PERSONAL/HOME CARE
19.2.1 CHRONIC PATIENTS
19.2.2 GERIATRIC PATIENTS
19.2.3 PREVENTIVE CARE/MONITORING
19.2.4 AND SHORT TERM AND OUTPATIENT CARE
19.3 INSTITUTIONAL
19.4 HOSPITALS & CLINICS
19.4.1 GENERAL HOSPITALS
19.4.2 SPECIALTY CLINICS
19.5 DIAGNOSTIC CENTERS
19.5.1 IMAGING CENTERS
19.5.2 PATHOLOGY LABS
19.6 HOME HEALTHCARE PROVIDERS
19.7 AMBULATORY SURGICAL CENTERS (ASCS)
19.8 LONG-TERM CARE FACILITIES
19.9 REHABILITATION CENTERS
19.10 ELDERLY CARE HOMES
19.11 SPECIALTY CLINICS
19.11.1 ONCOLOGY CLINICS
19.11.2 CARDIOLOGY CLINICS
19.11.3 MEDICAL NURSING HOMES
19.11.4 MEDICAL RESEARCH LABORATORIES/INSTITUTIONS)
19.11.5 OTHERS
20. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, BY COUNTRY
GLOBAL MEDICAL EQUIPMENT RENTAL MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
20.1 NORTH AMERICA
20.1.1 U.S.
20.1.2 CANADA
20.1.3 MEXICO
20.2 EUROPE
20.2.1 GERMANY
20.2.2 U.K.
20.2.3 ITALY
20.2.4 FRANCE
20.2.5 SPAIN
20.2.6 RUSSIA
20.2.7 SWITZERLAND
20.2.8 TURKEY
20.2.9 BELGIUM
20.2.10 NETHERLANDS
20.2.11 DENMARK
20.2.12 SWEDEN
20.2.13 POLAND
20.2.14 NORWAY
20.2.15 FINLAND
20.2.16 REST OF EUROPE
20.3 ASIA-PACIFIC
20.3.1 JAPAN
20.3.2 CHINA
20.3.3 SOUTH KOREA
20.3.4 INDIA
20.3.5 SINGAPORE
20.3.6 THAILAND
20.3.7 INDONESIA
20.3.8 MALAYSIA
20.3.9 PHILIPPINES
20.3.10 AUSTRALIA
20.3.11 NEW ZEALAND
20.3.12 VIETNAM
20.3.13 TAIWAN
20.3.14 REST OF ASIA-PACIFIC
20.4 SOUTH AMERICA
20.4.1 BRAZIL
20.4.2 ARGENTINA
20.4.3 REST OF SOUTH AMERICA
20.5 MIDDLE EAST AND AFRICA
20.5.1 SOUTH AFRICA
20.5.2 EGYPT
20.5.3 BAHRAIN
20.5.4 UNITED ARAB EMIRATES
20.5.5 KUWAIT
20.5.6 OMAN
20.5.7 QATAR
20.5.8 SAUDI ARABIA
20.5.9 REST OF MEA
20.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
21. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, SWOT AND DBMR ANALYSIS
22. GLOBAL MEDICAL EQUIPMENT RENTAL MARKET, COMPANY PROFILE
22.1 PRIME MEDICINE
22.1.1 COMPANY OVERVIEW
22.1.2 REVENUE ANALYSIS
22.1.3 GEOGRAPHIC PRESENCE
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENTS
22.2 SOMAGENETIX AG
22.2.1 COMPANY OVERVIEW
22.2.2 REVENUE ANALYSIS
22.2.3 GEOGRAPHIC PRESENCE
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 ORCHARD THERAPEUTICS
22.3.1 COMPANY OVERVIEW
22.3.2 REVENUE ANALYSIS
22.3.3 GEOGRAPHIC PRESENCE
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENTS
22.4 GÉNÉTHON
22.4.1 COMPANY OVERVIEW
22.4.2 REVENUE ANALYSIS
22.4.3 GEOGRAPHIC PRESENCE
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 MAXCYTE, INC.
22.5.1 COMPANY OVERVIEW
22.5.2 REVENUE ANALYSIS
22.5.3 GEOGRAPHIC PRESENCE
22.5.4 PRODUCT PORTFOLIO
22.5.5 RECENT DEVELOPMENTS
22.6 ROCKET PHARMACEUTICALS
22.6.1 COMPANY OVERVIEW
22.6.2 REVENUE ANALYSIS
22.6.3 GEOGRAPHIC PRESENCE
22.6.4 PRODUCT PORTFOLIO
22.6.5 RECENT DEVELOPMENTS
22.7 SANGAMO THERAPEUTICS
22.7.1 COMPANY OVERVIEW
22.7.2 REVENUE ANALYSIS
22.7.3 GEOGRAPHIC PRESENCE
22.7.4 PRODUCT PORTFOLIO
22.7.5 RECENT DEVELOPMENTS
22.8 SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE
22.8.1 COMPANY OVERVIEW
22.8.2 REVENUE ANALYSIS
22.8.3 GEOGRAPHIC PRESENCE
22.8.4 PRODUCT PORTFOLIO
22.8.5 RECENT DEVELOPMENTS
22.9 MAYO CLINIC
22.9.1 COMPANY OVERVIEW
22.9.2 REVENUE ANALYSIS
22.9.3 GEOGRAPHIC PRESENCE
22.9.4 PRODUCT PORTFOLIO
22.9.5 RECENT DEVELOPMENTS
22.10 BOSTON CHILDREN'S HOSPITAL
22.10.1 COMPANY OVERVIEW
22.10.2 REVENUE ANALYSIS
22.10.3 GEOGRAPHIC PRESENCE
22.10.4 PRODUCT PORTFOLIO
22.10.5 RECENT DEVELOPMENTS
RECENT DEVELOPMENTS NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
23. RELATED REPORTS
24. CONCLUSION
25. QUESTIONNAIRE
26. ABOUT DATA BRIDGE MARKET RESEARCH
